Catheter Precision (VTAK) Stock Price, News & Analysis

Company Overview

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Key Stats

• Today's Range: $0.23 to $0.25
• 50-Day Range: $0.19 to $0.60
• 52-Week Range: $0.16 to $8.40
• Volume: 804,037 shs
• Average Volume: 4.46 million shs
• Market Capitalization: $2.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Catheter Precision Stock Analysis - MarketRank™

Catheter Precision scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Catheter Precision.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.

Price to Book Value per Share Ratio

Catheter Precision has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

31.59% of the float of Catheter Precision has been sold short.

Short Interest Ratio / Days to Cover

Catheter Precision has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Catheter Precision has recently increased by 512.67%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Catheter Precision does not currently pay a dividend.

Dividend Growth

Catheter Precision does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

31.59% of the float of Catheter Precision has been sold short.

Short Interest Ratio / Days to Cover

Catheter Precision has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Catheter Precision has recently increased by 512.67%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

Search Interest

3 people have searched for VTAK on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Catheter Precision insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.95% of the stock of Catheter Precision is held by insiders.

Percentage Held by Institutions

Only 20.34% of the stock of Catheter Precision is held by institutions.

VTAK Stock Analysis - Frequently Asked Questions

How have VTAK shares performed this year?

Catheter Precision's stock was trading at $0.4491 at the start of the year. Since then, VTAK stock has decreased by 47.5% and is now trading at $0.2360.
View the best growth stocks for 2025 here.

When did Catheter Precision's stock split?

Catheter Precision's stock reverse split on Monday, July 15th 2024.The 1-10 reverse split was announced on Monday, July 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Catheter Precision's major shareholders?

Catheter Precision's top institutional shareholders include Armistice Capital LLC (2.84%) and Warberg Asset Management LLC (2.04%). Insiders that own company stock include David A Jenkins and Martin J Colombatto.
View institutional ownership trends.

How do I buy shares of Catheter Precision?

Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Catheter Precision own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB).

Company Calendar

• Today: 6/27/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NYSEAMERICAN:VTAK
• CIK: 1716621
• Web: www.catheterprecision.com
• Phone: 973-691-2000
• Fax: N/A
• Employees: 14
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$16.64 million
• Net Margins: -3,744.91%
• Pretax Margin: -3,242.41%
• Return on Equity: -153.90%
• Return on Assets: -68.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.21
• Quick Ratio: 0.19

Sales & Book Value

• Annual Sales: $420 thousand
• Price / Sales: 6.56
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.33 per share
• Price / Book: 0.19

Miscellaneous

• Outstanding Shares: 11,020,000
• Free Float: 10,692,000
• Market Cap: $2.76 million
• Optionable: N/A
• Beta: -0.85